Recent progress in transcriptomics, proteomics, and single-cell technologies is beginning to illuminate the heterogeneity and context-specific plasticity of astrocyte subtypes across disease states, offering an unprecedented opportunity to develop targeted interventions with cell-type and disease-stage selectivity
Glutathione 100,000mg, Ascorbic Acid 20,000mg, Co Q10 8,000mg, Nicotinamide 3000mg, Placenta 12,000mg, Collagen 12,000mg, Stemcell 12,000mg, Kojic Acid 4,000mg, Thioctic Acid 2,000mg, Collagen Peptide 10,000mg, Vitamin C 10,000mg, Alpha Lipoic Acid 2,400mg, Pro Co Enzyme Q10 10,000mg, Multivitamins 2,400mg, Pro Vitamin B3 B5 B12 12,000mg,Vitamin E 4,000mg
Nutritional intervention is expected to become the third major treatment modality alongside physical therapy and drug therapy, bringing significant benefits to patients with mild to moderate OA and effectively reducing the proportion of severe OA patients, which allow more people to avoid the adverse effects of repeated drug treatment and the potential risks of surgery and prosthesis replacement
ThinWorks offers B12 injections as part of their services, making them easily accessible for those seeking more than just a boost in B12 levels
